← All stories
Markets

AbCellera prices $200 million public offering at $9.75/share

2 sources ·3 articles ·2h ago

2 outlets - including Investing and Financialpost - are covering this story. VANCOUVER, British Columbia — AbCellera Biologics Inc. (Nasdaq: ABCL) (“AbCellera”) today announced the pricing of its oversubscribed underwritten public offering of 17,435,897 common shares at a price to the public of $9.75 per share and,…

Covered by 2 outlets

All coverage · 3 articles